Literature DB >> 2654357

Modeling absorption kinetics of subcutaneous injected soluble insulin.

E Mosekilde1, K S Jensen, C Binder, S Pramming, B Thorsteinsson.   

Abstract

Absorption of subcutaneously injected soluble insulin deviates markedly from simple first-order kinetics and depends both on the volume and concentration of the injected solution. This paper presents a model of the absorption process in which insulin is presumed to be present in subcutis in a low molecular weight form, a high molecular weight form, and an immobile form where the molecules are bound to the tissue. The model describes how diffusion and absorption gradually reduce the insulin concentrations in the subcutaneous depot and thereby shift the balance between the three forms in accordance with usual laws of chemical kinetics. By presuming that primarily low molecular weight insulin penetrates the capillary walls, the model can account for experimentally observed variations in the absorption rate over a wide range of volumes and of concentrations. The model is used to determine the effective diffusion constant D for insulin in subcutis, the absorption rate constant B for low molecular weight insulin, the equilibrium constant Q between high and low molecular weight insulin, the binding capacity C for insulin in the tissue, and the average life time T for insulin in its bound state. Typical values for a bolus injection in the thigh of fasting type I diabetic patients are D = 0.9 x 10(-4) cm2/min, B = 1.3 X 10(-2)/min, and Q = 0.13 (ml/IU)2. Binding of insulin in the tissue is significant only at small concentrations. The binding capacity is of the order of C = 0.05 IU/cm3 with a typical average life time in the bound state of T = 80.0 min. Combined with a simplified model for distribution and degradation of insulin in the body, the absorption model is used to simulate variations in plasma free insulin concentrations with different delivery schedules, i.e., bolus injection and dosage by means of an infusion pump. The simulations show that a pump repetition frequency of 1-2 per hr is sufficient to secure an almost constant plasma insulin concentration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654357     DOI: 10.1007/bf01059088

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  31 in total

1.  Adipose tissue blood flow and insulin disappearance from subcutaneous tissue.

Authors:  K Kølendorf; J Bojsen; S L Nielsen
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

2.  Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients.

Authors:  K Kølendorf; J Bojsen; T Deckert
Journal:  Diabetes Care       Date:  1983 Jan-Feb       Impact factor: 19.112

3.  Overnight metabolic control with pulsed intermittent versus continuous subcutaneous insulin infusion.

Authors:  C Levy-Marchal; A M Albisser; B Zinman
Journal:  Diabetes Care       Date:  1983 Jul-Aug       Impact factor: 19.112

4.  Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.

Authors:  T Deckert; B Hansen; K Kølendorf; J S Poulsen; M Smith
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-07

5.  Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

Authors:  J A Galloway; C T Spradlin; R L Nelson; S M Wentworth; J A Davidson; J L Swarner
Journal:  Diabetes Care       Date:  1981 May-Jun       Impact factor: 19.112

Review 6.  Insulin pharmacokinetics.

Authors:  C Binder; T Lauritzen; O Faber; S Pramming
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

7.  Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.

Authors:  K Køolendorf; J Bojsen; B Løorup
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

8.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

9.  Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.

Authors:  U Fischer; E J Freyse; E Jutzi; W Besch; M Raschke; S Höfer; G Albrecht
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

10.  Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.

Authors:  K Kølendorf; J Bojsen; T Deckert
Journal:  Horm Metab Res       Date:  1983-06       Impact factor: 2.936

View more
  37 in total

1.  Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling.

Authors:  W H O Clausen; A De Gaetano; A Vølund
Journal:  Diabetologia       Date:  2006-07-25       Impact factor: 10.122

2.  Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium.

Authors:  M S Roberts; S Lipschitz; A J Campbell; S Wanwimolruk; E G McQueen; M McQueen
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

Review 3.  Non-invasive delivery strategies for biologics.

Authors:  Aaron C Anselmo; Yatin Gokarn; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2018-11-30       Impact factor: 84.694

4.  Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes.

Authors:  Jiaxu Li; Yang Kuang
Journal:  Math Biosci Eng       Date:  2009-01       Impact factor: 2.080

Review 5.  Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.

Authors:  Harriet L Miles; Carlo L Acerini
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 6.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

Authors:  F Y Liu; D O Kildsig; A K Mitra
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

8.  Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator: 2. preliminary bench testing.

Authors:  Eldon D Lehmann; Cristina Tarín; Jorge Bondia; Edgar Teufel; Tibor Deutsch
Journal:  J Diabetes Sci Technol       Date:  2007-09

9.  Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator: 1. a prospective collaborative development plan.

Authors:  Eldon D Lehmann; Cristina Tarín; Jorge Bondia; Edgar Teufel; Tibor Deutsch
Journal:  J Diabetes Sci Technol       Date:  2007-05

10.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.